Ivor Royston

Directeur Général chez Viracta Subsidiary, Inc.

Profil

Ivor Royston was the founder of Hybritech, Inc. (1978), IDEC Pharmaceuticals Corp.
(1986), IDEC Corp.
(United States) (1986), and Forward Ventures Services LLC (1993) with the title of Managing Member at Forward Ventures Services LLC.
Dr. Royston is currently the President, Chief Executive Officer & Director at Viracta Subsidiary, Inc. and the Director at CONNECT.
Former positions include President, Chief Executive Officer & Director at Sunesis Pharmaceuticals, Inc., President & Chief Executive Officer at Sidney Kimmel Cancer Center (1990-2000), Chairman at Morphotek, Inc., Chairman at TargeGen, Inc., Director at Corautus Genetics, Inc., Director at CancerVax Corp., Director at Favrille, Inc. (2000-2009), Independent Director at Biocept, Inc. (2011-2023), Director at MyMedicalRecords, Inc., Independent Director at Syndax Pharmaceuticals, Inc. (2013-2017), Director at Viropro, Inc., Director at Avalon Pharmaceuticals, Inc., Director at Amgen Rockville, Inc., Director at LigoCyte Pharmaceuticals, Inc. (2006-2010), Director-Clinical Immunology at San Diego Cancer Center, Director at HemaQuest Pharmaceuticals, Inc., Director at Altair Therapeutics, Inc., Independent Director at MMRGlobal, Inc. (2013-2016), Director-Clinical Immunology at the University of California, Director at The Life Sciences Foundation, Director at Viracta Therapeutics, Inc. (2022-2025), and Member at the University of California San Diego (1978-1990).
Education includes undergraduate and doctorate degrees from The Johns Hopkins University (1967, 1970).

Postes actifs de Ivor Royston

Sociétés	Poste	Début
Viracta Subsidiary, Inc.	Directeur Général	01/01/2015
CONNECT	Directeur/Membre du Conseil	-

Anciens postes connus de Ivor Royston

Sociétés	Poste	Fin
VIRACTA THERAPEUTICS, INC.	Directeur Général	19/09/2022
BIOCEPT, INC.	Directeur/Membre du Conseil	13/10/2023
SYNDAX PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	01/03/2017
MMRGLOBAL, INC.	Directeur/Membre du Conseil	11/08/2016
Altair Therapeutics, Inc.	Directeur/Membre du Conseil	09/03/2011